5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.02▼ | 1.02▼ | 1.01▼ | 1.03▼ | 1.11▼ |
MA10 | 1.02▼ | 1.01▼ | 1.02▼ | 1.05▼ | 1.09▼ |
MA20 | 1.02▼ | 1.02▼ | 1.03▼ | 1.11▼ | 1.16▼ |
MA50 | 1.02▼ | 1.03▼ | 1.05▼ | 1.09▼ | 1.14▼ |
MA100 | 1.03▼ | 1.05▼ | 1.05▼ | 1.16▼ | 1.08▼ |
MA200 | 1.04▼ | 1.06▼ | 1.13▼ | 1.16▼ | 1.62▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.000▲ | -0.001▼ | -0.012▼ | -0.016▼ |
RSI | 40.690▼ | 39.078▼ | 32.578▼ | 40.239▼ | 44.642▼ |
STOCH | 16.667▼ | 30.556 | 6.667▼ | 16.928▼ | 36.434 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -89.749▼ |
CCI | -466.667▼ | -46.113 | -78.261 | -147.834▼ | -75.550 |
Monday, September 29, 2025 01:57 AM
The approval of Medicare coverage could potentially unlock a large market segment for Lucid Diagnostics' devices. Read why LUCD stock is a Hold.
|
Thursday, September 25, 2025 05:27 AM
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...
|
Thursday, September 11, 2025 07:47 AM
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 1.035 | 1.0392 | 1.01 | 1.01 | 789,667 |
29/09/25 | 1.03 | 1.0466 | 1.02 | 1.03 | 535,470 |
26/09/25 | 1.06 | 1.06 | 1.03 | 1.03 | 582,190 |
25/09/25 | 1.04 | 1.05 | 1.02 | 1.04 | 813,526 |
24/09/25 | 1.05 | 1.06 | 1.03 | 1.04 | 822,463 |
23/09/25 | 1.09 | 1.09 | 1.05 | 1.055 | 1,015,162 |
22/09/25 | 1.08 | 1.095 | 1.065 | 1.08 | 665,913 |
19/09/25 | 1.07 | 1.105 | 1.06 | 1.09 | 1,532,565 |
18/09/25 | 1.07 | 1.09 | 1.05 | 1.07 | 1,096,816 |
17/09/25 | 1.08 | 1.10 | 1.06 | 1.07 | 1,328,886 |
|
|
||||
|
|
||||
|
|